To investigate whether MARM2.0 could predict the responses of BRAFV600E colorectal cancers to RAFi, we collected data from HT29 cells, which carry a heterozygous BRAFV600E mutation and have high EGFR expression (similar to A375 EGFR‐CRISPRa cells). This evidence concerns the gene EGFR and colorectal cancer.